NSC |
Compound |
Enrichment |
Correlation |
NSC 128687 |
6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) |
0.00293992674122322 |
0.11912838 |
NSC 618296 |
Null |
0.00293992674122322 |
0.4871921 |
NSC 628121 |
Null |
0.00293992674122322 |
0.36204332 |
NSC 629749 |
.beta.-Lapachone |
0.00293992674122322 |
0.19876968 |
NSC 648365 |
Insulin-Methotrexate conjugate |
0.00293992674122322 |
0.13975602 |
NSC 676343 |
Null |
0.00293992674122322 |
0.32919663 |
NSC 679002 |
2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl]-, diethyl ester, cis- |
0.00293992674122322 |
0.12229549 |
NSC 704888 |
Fumaric acid, 2-[5-chloro-3-(2-ethoxy-2-oxoethyl)-2,4-dioxo- 1H,3H-pyrimidinyl]-, diethyl ester |
0.00293992674122322 |
0.17070818 |
NSC 711615 |
Null |
0.00293992674122322 |
0.41677076 |
NSC 723888 |
3-benzyl-2-methyl-4,5-dioxo-4,5-dihydro-3H-benzo[e]indole-1-carboxylic acid, ethyl ester |
0.00293992674122322 |
0.30451928 |